4.6 Article

Missed Opportunities for Adolescent Vaccination, 2006-2011

期刊

JOURNAL OF ADOLESCENT HEALTH
卷 53, 期 4, 页码 492-497

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jadohealth.2013.05.009

关键词

Vaccines; Adolescent health; Immunization assessment; Preventive health care visits

资金

  1. Society for Adolescent Health and Medicine (SAHM) Career Development Award

向作者/读者索取更多资源

Objective: To describe missed opportunities for meningococcal (MCV); tetanus, diphtheria, acellular pertussis (Tdap); and human papillomavirus (HPV) vaccination among adolescents. Methods: Retrospective electronic health record data review of adolescents aged 11-18 years at the time of their visit to a university-based pediatric practice in Seattle from 2006 to 2011. The primary outcome was missed vaccination opportunities, defined as the proportion of visits where a patient eligible for MCV, Tdap, and/or HPV remained unvaccinated. HPV vaccine analysis was limited to females. Bivariate and multivariate logistic regression assessed variables associated with missed vaccination opportunities. Results: During the study period, 1,628 adolescents made 9,180 visits. The percentage of visits that were missed opportunities was 82% for MCV, 85% for Tdap, and 82% for the first HPV dose (HPV1), 63% for the second, and 71% for the third. Adolescents with at least one preventive care visit were significantly less likely to have missed opportunities for MCV, Tdap, or HPV1. Nonpreventive visits were associated with more missed opportunities for MCV (OR = 19.2, 95% CI 15.3-24.0), Tdap (OR = 25.8, 95% CI 19.3-34.6), and HPV1 (OR = 12.1, 95% CI 9.0-16.1) than preventive visits. Adolescent females were more likely to have a missed opportunity for HPV1 than Tdap (p < .001) or MCV (p = .03). Conclusions: Missed opportunities for adolescent vaccination against MCV, Tdap and HPV are common. Adolescents who utilize preventive care are less likely to have missed vaccination opportunities. Further research is needed to explore why missed vaccination opportunities occur and to develop evidence-based strategies to reduce missed opportunities and improve adolescent vaccination coverage. (C) 2013 Society for Adolescent Health and Medicine. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

Skin and Mucosal Human Papillomavirus Seroprevalence in Persons with Fanconi Anemia

Rachel A. Katzenellenbogen, Joseph J. Carter, Joshua E. Stern, Melinda S. Butsch Kovacic, Parinda A. Mehta, Sharon L. Sauter, Denise A. Galloway, Rachel L. Winer

CLINICAL AND VACCINE IMMUNOLOGY (2015)

Article Virology

Human papillomavirus 16E6 and NFX1-123 potentiate notch signaling and differentiation without activating cellular arrest

Portia A. Vliet-Gregg, Jennifer R. Hamilton, Rachel A. Katzenellenbogen

VIROLOGY (2015)

Article Multidisciplinary Sciences

Human papillomavirus type 16 E6 and NFX1123 mislocalize immune signaling proteins and downregulate immune gene expression in keratinocytes

Justine Levan, Portia A. Vliet-Gregg, Kristin L. Robinson, Rachel A. Katzenellenbogen

PLOS ONE (2017)

Review Virology

Activation of telomerase by HPVs

Rachel A. Katzenellenbogen

VIRUS RESEARCH (2017)

Review Virology

Telomerase Induction in HPV Infection and Oncogenesis

Rachel Katzenellenbogen

VIRUSES-BASEL (2017)

Article Psychology, Developmental

Human Papillomavirus Vaccines: Factors That Affect Vaccine Knowledge and Delivery

Nneka A. Holder, Rachel Katzenellenbogen, Amy B. Middleman

JOURNAL OF ADOLESCENT HEALTH (2013)

Article Virology

NFX1 Plays a Role in Human Papillomavirus Type 16 E6 Activation of NFκB Activity

Mei Xu, Rachel A. Katzenellenbogen, Carla Grandori, Denise A. Galloway

JOURNAL OF VIROLOGY (2010)

Article Virology

NFX1-123 and Human Papillomavirus 16E6 Increase Notch Expression in Keratinocytes

Portia A. Vliet-Gregg, Jennifer R. Hamilton, Rachel A. Katzenellenbogen

JOURNAL OF VIROLOGY (2013)

Article Dentistry, Oral Surgery & Medicine

Detection of human papillomavirus in the oral cavities of persons with Fanconi anemia

R. L. Winer, C. E. Huang, S. Cherne, J. E. Stern, M. S. Butsch Kovacic, P. A. Mehta, S. L. Sauter, D. A. Galloway, R. A. Katzenellenbogen

ORAL DISEASES (2015)

Article Virology

An unbiased in vivo screen reveals multiple transcription factors that control HPV E6-regulated hTERT in keratinocytes

Mei Xu, Rachel A. Katzenellenbogen, Carla Grandori, Denise A. Galloway

VIROLOGY (2013)

Article Oncology

NFX1-123 is highly expressed in cervical cancer and increases growth and telomerase activity in HPV 16E6 expressing cells

Portia A. Vliet-Gregg, Kristin L. Robinson, Justine Levan, Lisa R. Matsumoto, Rachel A. Katzenellenbogen

CANCER LETTERS (2019)

Article Virology

HPV type 16 E6 and NFX1-123 augment JNK signaling to mediate keratinocyte differentiation and L1 expression

Justine Levan, Portia A. Vliet-Gregg, Kristin L. Robinson, Lisa R. Matsumoto, Rachel A. Katzenellenbogen

VIROLOGY (2019)

Article Otorhinolaryngology

High expression of NFX1-123 in HPV positive head and neck squamous cell carcinomas

Sreenivasulu Chintala, Kevin M. Quist, Patricia A. Gonzalez-DeWhitt, Rachel A. Katzenellenbogen

Summary: The study found that NFX1-123 and a subset of its known targets were increased in HPV+ HNSCCs, while LCE1B, KRT16, SPRR2G, and FBN2 were highly expressed in HNSCCs. Notch1 and CCNB1IP1 had greater expression in HPV+ HNSCCs compared to HPV- HNSCCs.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2022)

Review Virology

Post-Transcriptional Gene Regulation by HPV 16E6 and Its Host Protein Partners

Caylin L. Billingsley, Sreenivasulu Chintala, Rachel A. Katzenellenbogen

Summary: HPV 16, the most common oncogenic type of HPV, has a protein, E6, that disrupts normal cellular processes by binding cellular proteins and regulating gene expression; recent studies have found that 16E6 can also post-transcriptionally regulate cellular genes and pathways by binding cellular RNA processing and binding proteins, offering new insights for therapeutic strategies in HPV-associated cancers.

VIRUSES-BASEL (2022)

暂无数据